| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |